LCTX vs GILD: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Gilead Sciences Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
—
GILD
Gilead Sciences Inc
$136.30
Key Metrics Comparison
| Metric | LCTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $213.56M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze LCTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or GILD a better investment?
Comparing LCTX and GILD: Lineage Cell Therapeutics Inc has a market cap of $213.56M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and GILD?
LCTX (Lineage Cell Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or GILD?
Both LCTX and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: LCTX or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: LCTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $213.56M for LCTX.
Should I buy LCTX or GILD in 2026?
Both LCTX and GILD have investment merit. LCTX trades at $N/A while GILD trades at $136.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and GILD stock?
Key differences: Market Cap ($213.56M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy LCTX or GILD in 2026?
The choice between LCTX and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between LCTX and GILD?
LCTX (Lineage Cell Therapeutics Inc) has a market cap of $213.56M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.